Evidence map›Paper›PMID 33263520›Full record

ArticleBlood transfusion = Trasfusione del sangue2022

Molecular characterization of rare D--/D-- variants in individuals of Indian origin.

Swati Kulkarni, Garima Mishra, Harita Maru, Disha Parchure, Debasish Gupta, Anantpreet Kaur Bajaj, Sangeeta Pahuja Sindhwani, Anand Chaphekar, Ripal Shah, Claude Férec and 2 more

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Unveiling Novel and Rare Variants in theTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2025
    Article
  2. Article
  3. Defining the breakpoints of hybrid blood group alleles.Blood transfusion = Trasfusione del sangue · 2024
    Article
  4. A Rare RhD-Phenotype Caused by GeneIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Swati KulkarniDepartment of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India.
Garima MishraDepartment of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India.
Harita MaruDepartment of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India.
Disha ParchureDepartment of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India.
Debasish GuptaDepartment of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
Anantpreet Kaur BajajDepartment of Immunhaematology and Blood Transfusion, Armed Forces Medical College, Pune, India.
Sangeeta Pahuja SindhwaniDepartment of Immunhaematology and Blood Transfusion, Lady Hardinge Medical College, New Delhi, India.
Anand ChaphekarKEM Hospital Blood Bank, Pune, India.
Ripal ShahPrathama Blood Centre, Ahmedabad, India.
Claude Férec"Génétique, Génomique Fonctionnelle et Biotechnologies", INSERM, EFS, Université de Brest, UMR1078, IBSAM, Brest, France.
Manisha MadkaikarDepartment of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India.
Yann Fichou"Génétique, Génomique Fonctionnelle et Biotechnologies", INSERM, EFS, Université de Brest, UMR1078, IBSAM, Brest, France.
Sree Chitra Thirunal Institute for Medical Sciences and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRh antigens are critical in haemolytic disease of the foetus and newborn (HDFN). The D-- phenotype is a rare blood group characterised by the lack of expression of C, c, E and e antigens at the surface of red blood cells because of mutations in both RHCE alleles inactivating the expression of a "normal" protein. The aim of the study was to determine the molecular basis of D-- individuals of Indian origin. MATERIALS AND

methodsTen Rh D-positive postnatal women who had produced antibodies against all Rh antigens, except D, leading to HDFN and foetal loss, were investigated. Extensive serological and molecular (polymerase chain reaction [PCR] using sequence-specific primers), quantitative multiplex PCR of short fluorescent fragments (QMPSF), and Sanger sequencing analyses were carried out.

resultsSerological testing with anti-C, anti-c, anti-E, and anti-e reagents showed absence of the four antigens in all ten index cases, as well as in three siblings. Flow cytometry indicated absence of these antigens with a typical exalted expression of the D antigen, thus confirming the rare D-- phenotype. Molecular analysis by QMPSF suggested homozygous CE-D hybrid alleles causing the D-- phenotype: RHCE-D(3-9)-CE (n = 11), RHCE-D(3-8)-CE (n=1), and RHCE-D(2-6)-CE (n=1). DISCUSSION: For the first time, we report the molecular basis of the D-- phenotype in the Indian population. Identification and characterisation of RHCE-null variants by molecular methods can help resolve transfusion-related problems in these individuals. Family studies of index cases helped to identify rare blood donors and offer counselling to females of child-bearing age on the complications involved in such pregnancies.

Indexed as

Blood Group AntigensErythroblastosis, FetalAllelesFemaleHumansPhenotypePregnancyRh-Hr Blood-Group SystemBlood Group AntigensRh-Hr Blood-Group System

Identifiers

PMID33263520
PMCPMC8796842
OpenAlexW3106664336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.